HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

Second quarter revenues are estimated to be up 50% to $41.3 mil. on "exceptionally" strong sales of prestige fragrances in North America as well as launches and geographic expansion of Burberry, S.T. Dupont and Paul Smith scents, company reports July 10. In constant dollars, sales will be up 38%. Firm also raises full year guidance, projecting sales will be up 27%-29% to $165 mil.-$168 mil. compared to previous forecast of $150 mil. if the dollar remains at current levels. Net income expected to advance 23%-26% to $11.6 mil.-$11.8 mil., versus prior guidance of $11 mil. Sales in the second half of the year will benefit from launches of Burberry Brit and Diane von Furstenberg fragrance and cosmetics, which has had "stronger" initial orders from retailers than originally anticipated (1"The Rose Sheet" June 23, 2003 p. 6 and 2"The Rose Sheet" June 2, 2003, p. 11)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel